Protective Effect of Heme Oxygenase-1 Gene Transfer against Oxyhemoglobin-Induced Endothelial Dysfunction
Open Access
- 1 October 2001
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 21 (10) , 1215-1222
- https://doi.org/10.1097/00004647-200110000-00010
Abstract
The current study was designed to determine the effect of recombinant heme oxygenase-1 (HO-1) gene expression on endothelial function in cerebral arteries. Isolated canine basilar arteries were exposed ex vivo (30 minutes at 37°C) to an adenoviral vector (1010 PFU/mL, total volume 300 μL) encoding either the HO-1 gene (AdCMVHO-1) or the β-galactosidase (β-Gal) reporter gene (AdCMVβ-Gal). Twenty-four hours after transduction, arterial rings were suspended in organ chamber for isometric force recording. Endothelium-dependent relaxations were obtained in response to bradykinin (10−10 to 10−6 mol/L) during contraction to uridine-5′-triphosphate (UTP; 3 × 10−6 to 3 × 10−5 mol/L). Certain rings were incubated with oxyhemoglobin (OxyHb; 10−5 mol/L) overnight (16 to 18 hours of 24 hours). Expression and localization of recombinant protein were shown by Western blot analysis and immunohistochemistry. Endothelium-dependent relaxation to bradykinin and endothelium-independent relaxation to forskolin (10−9 to 10−5 mol/L) and DEA-NONOate (10−10 to 10−5 mol/L) were identical in β-Gal– and HO-1–transduced arteries. Exposure to OxyHb caused impairment of endothelium-dependent relaxation to bradykinin ( P < 0.01). In contrast, OxyHb did not affect endothelium-dependent relaxation in arteries expressing recombinant HO-1 ( P > 0.05). This protective effect of HO-1 was reversed by coincubation with tin protoporphyrin (SnPP9; 10−5 mol/L), a selective inhibitor of HO-1 ( P < 0.01). Basal levels of 3′,5′-cyclic monophosphate (cGMP) in HO-1–transduced vessels were not significantly different from those in β-Gal–transduced vessels. Pretreatment with OxyHb significantly reduced cGMP level in β-Gal–transduced rings ( P < 0.01), whereas it had no effect in HO-1–transduced rings. These results demonstrate that HO-1 gene transfer does not affect endothelial and smooth muscle function of normal arteries, and that expression of recombinant HO-1 in cerebral arteries protects vasomotor function against OxyHb-induced injury.Keywords
This publication has 31 references indexed in Scilit:
- Site-specific modifications and toxicity of blood substitutesAdvanced Drug Delivery Reviews, 2000
- Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injuryJournal of Clinical Investigation, 1999
- Haem oxygenase-1 prevents cell death by regulating cellular ironNature Cell Biology, 1999
- Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genesNature Medicine, 1998
- Expression and Function of Recombinant Endothelial Nitric Oxide Synthase Gene in Canine Basilar ArteryCirculation Research, 1997
- Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury.American Journal of Respiratory Cell and Molecular Biology, 1996
- Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial cells: protective effect against heme and hemoglobin toxicity.Proceedings of the National Academy of Sciences, 1995
- Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damageBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1994
- Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer.Proceedings of the National Academy of Sciences, 1994
- Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage.Proceedings of the National Academy of Sciences, 1993